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The glycoprotein E (gE) and thymidine kinase (TK) genes  are virulence-associated  
genes of pseudorabies virus (PrV). The study conducted was to shut down the gE 
gene from an established local TK defective (TK¯) PrV strain (TK¯gE+PrV). The 
ultimate aim of the study was to develop a gene-deleted   recombinant PrV   with  
useful  identification markers.  
 
A gE gene-deleted pseudorabies virus (TK¯gE¯PrV) was constructed   by 
homologous recombinational techniques. The TK¯gE+PrV, regarded as the parental 
strain in the study, originated from a virulent local PrV isolate (TK+gE+PrV). Prior 
to the construction of the TK¯gE¯PrV, the gE of the parental strain was amplified, 
cloned and studied. Comparative sequence analysis showed that the gE sequence of 
TK¯gE+PrV  was closely  identical (98 %) to a Chinese Ea strain. The  10 nucleotide 
variations at nucleotide positions 237, 931, 1207, 1409, 1501, 1530, 1549, 1555, 
1682 and 1842, led to six amino acids substitutions at amino acid residues 403 (A 
P), 470 (VA), 501 (VI), 517 (PS), 519 (TA) and 561 (TN) in their open 
reading frames  (ORFs) that code a  578 amino acid polypeptide. All 10 cystein 
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clusters in the gE sequences of the  PrV strains namely TK¯gE+ PrV, Ea strain and 
Rice strain were conserved. Despite the low overall level of amino acid sequence 
identity among the gE proteins (23 to 31%) of  diverse animal  species, the cystein 
clusters were relatively well conserved especially in the  C-terminal  of the protein. 
The  500 bp deletion introduced into  TK¯gE+ PrV  gE gene,  was designed to 
remove three cystein residues and one potential N-glycosylation  site at the C-
domain of gE, while maintaining sufficient flanking regions within the gE gene to 
facilitate homologous recombination.  
 
The  TK¯gE¯PrV constructed was identified by gene specific PCR assay, gE-PCR 
profiles and sequence analysis. Expression analysis by SDS-PAGE and 
immunoblots proved the absence of gE protein. The absence of gE-specific 
antibodies  in the serum of TK¯gE¯PrV immunized murine models further 
substantiated the evidence. Besides, the protective nature of  TK¯gE¯PrV resembled 
that of  parental strain (TK¯gE+PrV). Based on the gE deletion site,  TK¯gE¯PrV 
can be clearly differentiated from other PrV vaccine strains. Overall, the gE deletion 
was proven to be a functional genetic cum serologic marker.  
 
It is intriguing to know whether the virus is useful to deliver and express a foreign 
gene within the gE expression locus. Therefore, an E2 gene expression cassette, 
originally from classical swine fever (CSFV), was specially designed to be 
incorporated into the deleted gE gene as a foreign insert. It serves as a CSFV marker 
as well as for its immunogenic and protective properties against CSFV infection. An 
eukaryotic expression vector was constructed to express the CSFV E2 gene with 
specific functional domains. Following  transfection of mammalian cells with the E2 
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encoded naked plasmid (pCDNA+E2), E2 protein was detected using  
immunoperoxidase staining, SDS-PAGE and  immunoblot analyses. Before the gene 
was introduced into the gE gene of PrV, the ability of the expression plasmids to 
induce immune response in vivo was also evaluated in mice via gene gun and  
intramuscular injections. Both humoral and cell-mediated immunity were detected. 
Therefore, the CSFV E2 expression cassette developed was determined to be 
appropriate for a recombinant with  TK¯gE¯ PrV.  
 
The recombinant PrV was successfully developed, primarily by genetically 
modifying the transfer plasmid. The pUC plasmid was manipulated and constructed 
to harbor the E2 expression cassette with flanking PrV gE nucleotide regions to 
facilitate homologous recombinant. The  construct was transferred into TK¯gE¯ PrV 
genome by homologous crossovers DNA recombination. The expression of the E2 
gene in a viral plaque indicated a successful integration of the gene in  PrV genome. 
The formation of designated TK¯gE¯E2+PrV virus particles were  verified by means 
of PCR and sequence analysis.   
 
Based on its characteristics, generally it is concluded that  the gene deleted 
pseudorabies virus, TK¯gE¯PrV,  is a good candidate  for preparation of an 
attenuated vaccine as well as a viral vector.  
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Gen glikoprotein E (gE) dan timidina kinase (TK) merupakan gen terkait virulens 
virus pseudorabies (PrV).  Kajian ini telah dijalankan untuk mengancing gen gE 
daripada suatu strain tempatan PrV (TK¯gE+PrV) cacat TK (TK¯) yang tertubuh.  
Matlamat akhir kajian ini ialah untuk mengembangkan PrV rekombinan terhapus 
gen yang mempunyai penanda pengenalpastian berguna. 
 
Virus pseudorabies terhapus gen gE (TK¯gE+PrV) telah dibentuk melalui teknik 
rekombinasi homologus.  TK¯gE+PrV yang dianggap sebagai strain induk dalam 
kajian ini, adalah berasal daripada pencilan PrV tempatan virulen (TK+gE+PrV).  
Sebelum pembentukan TK¯gE¯PrV ini, gE daripada strain induk terlebih dahulu 
diamplifikasikan, diklon dan dikaji.  Analisis jujukan bandingan menunjukkan yang 
jujukan gE TK¯gE+PrV  adalah bersecaman rapat (98%) dengan strain Ea Cina.  
Ada 10 perbezaan nukleotida pada kedudukan 237, 931, 1207, 1409, 1501, 1549, 
1555, 1682, dan 1842, yang membawa kepada penggantian enam asid amino pada 
residu asid amino 403 (AP), 470 (VA), 501 (VI), 517 (PS), 519 (TA) 
dan 561 (TN) pada rangka bacaan terbukanya (ORF) yang mengekodkan suatu 
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polipeptida 578 asid amino.  Kesemua 10 gugusan sisteina dalam jujukan gE strain 
PrV, iaitu TK¯gE+PrV, EA dan Rice masih terpelihara.  Walaupun aras sepercaman 
keseluruhan jujukan asid amino di kalangan protein gE pelbagai spesies haiwan itu 
rendah (23 hingga 31%), gugusan sisteina adalah agak terpelihara dengan baik pada 
C-penghujung protein.  Penghapusan 500 kb yang diperkenalkan kepada gen gE 
TK¯gE+PrV, adalah direka bentuk untuk mengeluarkan tiga residu sisteina dan satu 
tapak berpotensi N-pengglikosilan dalam C-domain gE, sambil mengekalkan 
secukupnya kawasan sisi dalam gen gE untuk memudahkan rekombinasi 
homologus. 
 
TK¯gE¯PrV  yang dibentuk itu dikenal pasti melalui assai PCR khusus gen, profil 
gE-PCR, dan analisis jujukan.  Analisis penyataan melalui SDS-PAGE dan 
imunosap telah mengesahkan ketiadaan protein gE.  Ketiadaan antibodi gE-khusus 
dalam serum model murin terimun TK¯gE¯PrV telah menyokong bukti ini.   
Tambahan pula sifat pelindung  TK¯gE¯PrV  menyerupai strain induk 
(TK¯gE+PrV).   Berasaskan tapak penghapusan gE, TK¯gE¯PrV  secara jelas boleh 
dibezakan daripada strain vaksin PrV lain.  Secara keseluruhan, penghapusan gE ini 
membuktikan yang ianya adalah penanda genetik dan serologi berfungsi. 
 
Perkara yang menarik perhatian ialah sama ada virus ini berguna untuk pembawaan 
dan penyataan suatu gen asing dalam lokus penyataan gE.  Oleh itu, satu kaset 
penyataan gen E2, yang asalnya daripada virus demam babi klasik (CSFV), telah 
direka bentuk khusus untuk dimasukkan ke dalam gen gE terhapus sebagai suatu 
selitan asing.  Ianya bertindak sebagai penanda CSFV dan juga dipilih kerana sifat 
imunogenik dan perlindungannya terhadap jangkitan CSFV.  Satu vektor penyataan 
eukariot telah dibentuk untuk menyatakan gen E2 CSFV dengan domain fungsian 
khusus.  Berikutan transjangkitan sel mamalia dengan plasmid yang mengekodkan 
gen E2  (pCDNA+E2), protein E2 dikesan melalui pewarnaan imunoperoksidase, 
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SDS-PAGE, dan analisis imunosap.  Sebelum gen diperkenalkan kepada gen gE 
PrV, keupayaan plasmid penyataan untuk mengaruh gerak balas imun in vivo dinilai 
juga dalam mencit melalui penembak gen dan suntikan intraotot.  Kedua-dua 
keimunan humoral dan berantarakan sel telah dikesan.  Dengan ini, kaset penyataan 
E2CSFV yang dikembangkan itu telah dipastikan sesuai untuk rekombinasi dengan 
TK¯gE¯PrV.   
 
PrV rekombinan telah berjaya dikembangkan, khususnya melalui pengubahsuaian 
genetik plasmid pemindah.  Plasmid pUC telah dimanipulasi dan dibentuk untuk 
mengandungi kaset penyataan E2 dengan kawasan nukleotida gE PrV pada sisinya 
untuk memudahkan rekombinasi homologus.   Struktur ini telah dipindah ke dalam 
genom TK¯gE¯PrV  melalui rekombinasi DNA lintas  homologus.  Penyataan gen 
E2 dalam plak virus menunjukkan integrasi gen dalam genom PrV telah bejaya 
dilakukan.  Pembentukan zarah virus TK¯gE¯E2+PrV matlamat telah disah betul 
melalui PCR dan analisis jujukan. 
 
Berasaskan cirinya, secara umum kesimpulannya ialah, virus pseudorabies terhapus 
gen, TK¯gE¯PrV  merupakan calon yang baik untuk penyediaan vaksin teratenuat 
dan sebagai vektor virus. 
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BHV  Bovine herpesvirus 
bp   Base pair 
BSA   Bovine serum albumin 
BUK  Bucharest  strain of pseudorabies 
BVD   Bovine viral diarrhoea   
BVDV   Bovine viral diarrhoea virus  
C protein  Nonglycosylated nucleocapsid protein 
cDNA   Complementary deoxyribonucleic acid 
CEF   Chicken embryo fibroblast 
CHV   Canine herpesvirus 
CMI   Cell mediated immunity 
CMV  Cytomegalovirus 
CNS   Central nervous system 
CO2 Carbondioxide 
CPB   Citrate-phosphate buffer  
CPE  Cytopathic effect 
CRPV   Cotton-tail rabbit papillomavirus  
CSF   Classical swine fever 
CSFV   Classical swine fever virus 
C-terminal COOH-terminal  
CTL   Cytotoxic T-lymphocytes 
CVV  Crystal violet vaccine  
DAB  3’-3’-diaminobenzidine-hydrochloride 
DEPC   Diethyl pyrocarbonate  
DIVA    Differentiating infected from vaccinated animals 
DMSO   Dimethylsulfoxide 
DNA  Deoxyribonucleic acid 
dNTP   Deoxynucleotide triphosphate 
DTH  Delayed type hypersensitivity 
DTT   Dithiothreitol 
EDTA  Ethylene diamine tetra-acetate 
EHV  Equine herpesvirus 
ELISA   Enzyme-linked immunosorbent assay 
ER   Endoplasmic-reticulum 
Fab  Antigen binding fragment 
FAO  Food and Agriculture Organization 
Fc  Crystallizable fragment  
FC  Final concentration 
FCS   Foetal calf serum 
 
 xxi
  
FHV  Feline herpesvirus 
FMDV   Foot and mouth disease virus  
g.g.   Gene gun 
GaHV   Gallid herpesvirus 
gE   Glycoprotein E 
GPK   Guinea pig kidney cells 
H  Haemagglutinin  
H2O2   Hydrogen peroxide 
hCMV   Human cytomegalovirus 
HIS   Hyperimmune serum  
HIV   Human immunodeficiency virus 
hr   Hour 
HR  Homologous recombination 
HRP   Horseradish peroxidase 
HSV  Herpes simplex virus 
i.d.   Intradermal 
i.m.   Intramuscular 
IgG  Immunoglobulin G 
IL   Interleukin 
IPTG  Isopropylthiogalactosidase 
IR  Inverted repeat sequence 
kb   Kilobase pair 
kDa  Kilodalton 
LB   Lennox L  medium 
M   Molar 
m.o.i   Multitude of infection 
MAb   Monoclonal antibody  
MDV  Marek’s disease virus 
MEM  Minimum essential media 
MHC   Major histocompatibility complex 
min   minute 
ml   Mililitre 
mm   Milimetre 
mM   Milimolar 
mRNA  Messenger ribonucleic acid 
MVP   Malaysian Vaccine and Pharmaceuticals, Puchong, Malaysia 
NCBI  National Center for Biotechnology Information 
NDV  Newcastle disease virus 
ng   nanogramme 
nm   nanometer 
NS3  Non-structural protein 3; conserved among pestiviruses 
N-terminal H2N-terminal 
OD   Optical density 
OIE    Office International des Epizooties 
ORF   Open reading frame 
PBS   Phosphate-buffer saline 
PBST   Phosphate-buffer saline tween 20 
PCR   Polymerase chain reaction  
PFU  Plaque forming unit 
PRRSV  Porcine reproductive and respiratory syndrome virus  
 xxii
  
PrV   Pseudorabies virus 
PVDF  Polyvinylidene fluoride membrane 
RE   Restriction endonuclease 
RNA   Ribonucleic acid 
RR   Ribonucleotide reductase 
RT   Room temperature 
RT-PCR  Reverse transcriptase polymerase chain reaction 
RV   Rabies virus 
SAPS   Statistical analysis of  protein sequence  
SAPS   Statistical analysis of protein sequence 
SDS   Sodium dodecyl sulfate 
SDSC   San Diego Supercomputer Center 
SDS-PAGE   Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
sec   Second 
SHV  Simian herpesvirus 
SPF   Specific pathogen free 
STE   Swine testicle  
SVV  Simian varicella virus 
TA  Tibialis anterior muscle  
TE  Tris-EDTA 
TGN  Trans-golgi network  
Th   T-lymphocyte helper 
TK   Thymidine kinase 
TK¯gE¯ PrV Pseudorabies virus with defective in TK and gE genes 
TK¯gE¯E2+ PrV An E2 gene ( of CSFV) recombinant pseudorabies virus with 
defective  TK and gE PrV genes 
TK¯gE+ PrV  Pseudorabies virus with defective TK gene  
TK+gE+ PrV  Wild type pseudorabies  
TMAP   Prediction of transmembrane segments 
TMR   Transmembrane region 
TNE   Tris-NaCl-EDTA 
TR   Terminal repeat 
U   Unit 
UL  Unique Long Sequence 
US  Unique Short Sequence 
UTR  Untranslated Region 
UV   Ultraviolet 
μ micron 
μg   microgramme 
v/v  volume/volume 
Vero   African green monkey kidney cell 
VZV   Varicella zoster virus 
w/v   Weight/volume 
WEE  Western equine encephalitis  
xg   gravity 
X-gal   5-bromo-4-chloro-3-indolyl-β-D-galactoside 
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LIST OF NOTATION 
 
The names of the 20 common amino acids and their corresponding three-letter 
abbreviation and single letter code. 
 
   
Amino acid Three-letter
code 
Single-letter 
code 
Alanine 
Arginine 
Asparagine 
Aspartic acid 
Cysteine 
Glutamine 
Glutamic acid 
Glycine 
Histidine 
Isoleucine 
Leucine 
Lysine 
Methionine 
Phenylalanine
Proline 
Serine 
Threonine 
Tryptophan 
Tyrosine 
Valine 
Ala 
Arg 
Asn 
Asp 
Cys 
Gln 
Glu 
Gly 
His 
Ile 
Leu 
Lys 
Met 
Phe 
Pro 
Ser 
Thr 
Trp 
Tyr 
Val 
A 
R 
N 
D 
C 
Q 
E 
G 
H 
I 
L 
K 
M 
F 
P 
S 
T 
W 
Y 
V 
 
 
